Why the study?
Inflammatory markers and poor glycemic control are associated with cardiovascular complications, prompting evaluation of the association between CRP and HbA1c in ischemic heart disease patients.
Is there a correlation between glycemic control (HbA1c) and systemic inflammation (CRP) in patients with ischemic heart disease?
Population
668 patients with ischemic heart disease undergoing coronary angiography
Comparison
CRP categories and HbA1c levels (<6.5% vs ≥6.5%)
Design
Cross-sectional study
Key result
HbA1c levels were significantly and positively correlated with CRP levels (r=0.220, p=0.001) in patients with ischemic heart disease.
Authors
Loading...
Association between HbA1c and CRP in IHD is hypothesis-generating; leaves open causality and should not yet change practice.
Cross-Sectional (n=668)
No
Is there a correlation between glycemic control (HbA1c) and systemic inflammation (CRP) in patients with ischemic heart disease?
Effect estimate: r=0.220
p-value: p=0.001
Ahmed et al. (2018) conducted a cross-sectional in Ischemic heart disease (n=668). HbA1c and CRP assessment was evaluated on Correlation between HbA1c and CRP (r=0.220, p=0.001). HbA1c levels were significantly and positively correlated with CRP levels (r=0.220, p=0.001) in patients with ischemic heart disease.